E-traveltraffic.com
Clinical Trials Update: March 31, 2006:Posted By: Janine Delacroix (HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:Healthy Patient Studies This study will evaluate the safety and tolerability of a drug that is a member of a relatively new class of agents, triple monoamine reuptake inhibitors. Participants must be non-smokers and agree to follow certain restrictions for the entire duration of the study. Restrictions -- unless medically necessary -- include no alcohol, no caffeine, and no grapefruit products, as well as no prescription, over-the-counter medications, or herbal or dietary supplements. The research site is in Glendale, Calif. More Information Please see http://www.centerwatch.com/patient/studies/phasei.html. ----- Cushing's Disease Novartis is conducting a study to assess the effectiveness and tolerability of multiple doses of a study drug in patients with Cushing's disease. Volunteers must be 18 years or older, have diagnosed Cushing's disease based on lab results, and be able to complete at least 15 days of study drug treatment. Female patients must not be pregnant and must agree to use acceptable forms of birth control during the study, and for one month afterward. The research sites are in Boston, Mass., and Los Angeles, Calif. More Information Please see http://www.centerwatch.com/patient/studies/cat651.html. ----- Insomnia To qualify for participation in this study of an investigational treatment for insomnia, you must be: 18 years or older, generally in good health, and experiencing insomnia symptoms for at least three months. Participation includes study visits with a medical professional, investigational study drug, and study procedures and tests. Compensation for incidental costs and travel may be provided. The research site is in Chesapeake, Va. More Information Please see http://www.centerwatch.com/patient/studies/cat189.html. ----- Copyright 2006 CenterWatch. All rights reserved. Courtesy Of: Yahoo! News The information reported above is property of Yahoo! inc. and reprinted or modified with legitimate permission. We thank Yahoo! inc. for the kind cooperation with us and other shareholders. |
|
Bookmark | Contact Us | Search
Copyright ©2005-2008 MAS Network